TerrAscend Corp.

TSX:TSND.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$0.52 -1.61%

-$0.02 today

Market cap
$193.65M
Beta
2.04
P/E (TTM)
-2.5
EPS (TTM)
-$0.26
52W Low $0.33High $2.00

Volume 0.26M

Average 0.31M

TSND.TO Income Tax Expense

Income taxes recognized for the period, including current and deferred tax.

TerrAscend Corp.TSX: TSND.TO

Income Tax Expense · Q1 FY2026 · quarter ended Mar 2026

Income tax expense dips below year-ago levels

Q1 FY2026 income tax expense of $10.08M fell 11.9% year over year, behind the +30.6% change in trailing-twelve-month income tax expense.

Context

  • Income tax expense amounted to 11.3% of revenue in FY2025, up 4.6 pp from a year earlier.
  • Income tax expense increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -11.9% toward the trailing-twelve-month pace of +30.6%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$10.08M+693.5% QoQ
Last fiscal yearDec 2025
$29.98M+46.7% YoY
LTMMar 2026
$29.02M+30.6% YoY
Income Tax Expense past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-11.9%——
1 year+46.7%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Income Tax Expense history

USD · from the income statement

Latest · FY2025
29.98M USD
Year-over-year change
+46.7%
4-year CAGR
+0.9%

Income Tax Expense vs competitors

How TSND.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so income tax expense is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +30.6% is the 4th highest of 10, against a peer median of -99.7%.
  • Income tax expense amounts to 11.1% of revenue for TSND.TO, versus a peer median of 0.9%.
TSND.TO Competitors
Income Tax Expense for TSND.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
TSND.TOTerrAscend Corp.LTM Mar 2026$29.02M USD+30.6%—11.1%
DR.TOMedical Facilities CorporationLTM Mar 2026$10.69M USD+267.5%-1.0%3.5%
EPRX.TOEupraxia Pharmaceuticals Inc.LTM Mar 2026$28.82K USD+200.2%——
WEED.TOCanopy Growth CorporationLTM Mar 2026CA$23K CAD-99.7%—0.0%
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 2026$0 USD-100.0%-10.3%0.0%
HLS.TOHLS Therapeutics Inc.LTM Mar 2026-$429.98K USD-110.5%—0.8%
XLY.TOAuxly Cannabis Group Inc.LTM Mar 2026-CA$1.21M CAD+85.1%—0.8%
ACB.TOAurora Cannabis Inc.LTM Mar 2026-CA$3.25M CAD-170.4%—1.0%
CPH.TOCipher Pharmaceuticals Inc.LTM Mar 2026-$10.76M USD-45.9%—21.1%
OGI.TOOrganiGram Holdings Inc.LTM Mar 2026-CA$13.66M CAD-17878.9%—5.0%
Peer median (excluding TSND.TO) —-99.7%-5.6%0.9%

Competitors are the stored peer set for TSND.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue243.36M240.45M317.33M306.68M265.12M
Cost of Revenue109.32M203.35M112.49M156.72M131.93M
Gross Profit134.04M119.74M138.02M149.96M133.19M
Gross Margin55.1%49.8%43.5%48.9%50.2%
Research & Development00000
Selling, General & Admin73.71M116.64M112.17M111.33M82.41M
Operating Expenses94.12M150.69M179.56M167.07M87.78M
Depreciation & Amortization13.63M24.6M22.7M22.99M17.51M
EBITDA44.96M(246.52M)(1.03M)6.16M62.92M
EBITDA Margin18.5%-102.5%-0.3%2.0%23.7%
Operating Income31.33M(23.04M)(19.87M)(17.11M)45.41M
Operating Margin12.9%-9.6%-6.3%-5.6%17.1%
Interest Income00000
Interest Expense24.57M37.9M35.11M35.4M36.93M
Other Income / Expenses12.46M(277.92M)(38.97M)(35.13M)(40.34M)
Income Before Tax43.78M(300.95M)(58.83M)(52.23M)5.06M
Pre-Tax Margin18.0%-125.2%-18.5%-17.0%1.9%
Income Tax Expense28.88M(10.46M)23.45M20.44M29.98M
Net Income3.06M(303.96M)(91.1M)(80.23M)(87.74M)
Net Margin1.3%-126.4%-28.7%-26.2%-33.1%
EPS (Basic)0.07(1.31)(0.32)(0.28)(0.29)
EPS (Diluted)0.01(1.31)(0.32)(0.28)(0.29)
Weighted Avg Shares181.06M244.35M279.29M291.51M301.08M
Weighted Avg Shares (Diluted)208.71M244.35M279.29M291.51M301.08M

TerrAscend Corp.

TSX:TSND.TO

Intrinsic Alpha fair value

Locked

Current Price

$0.52

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.